ADImmune Corporation Plans To Sell Its Flu Vaccine In China This Year

Published: Jan 07, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

January 7, 2013 -- Adimmune of Taiwan has completed a China Phase III trial of its trivalent flu vaccine in 1,200 people. It expects CFDA approval in mid-2014, which will allow the company to market the vaccine in mainland China in time for the 2014-2015 flu season, making it the first Taiwanese company to provide a vaccine to China. Adimmune is the only GMP-certified vaccine maker in Taiwan. More details....

Help employers find you! Check out all the jobs and post your resume.

Back to news